MFDS
- Marketing authorisation holder: LILLY
- Status: likely_approved
🇰🇷 Pagitane in South Korea
Pagitane (CYCRIMINE) regulatory status in South Korea.
Marketing authorisation
Pagitane in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Neuroscience approved in South Korea
Frequently asked questions
Is Pagitane approved in South Korea?
Yes. MFDS has authorised it.
Who is the marketing authorisation holder for Pagitane in South Korea?
LILLY holds the South Korean marketing authorisation.